Buy Beam Therapeutics Stock | BEAM Stock Price & Latest News | Public.com

Beam Therapeutics

$0.00 (0.00%)Today

About BEAM

Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing....Read more

Community

People who own or watch this stock

Buy any stock with any amount of money.

Download the App
Download the app

What Wall Street Thinks

Rating

What Wall St. analysts suggest for this stock

1

Price Targets

What analysts think this stock will be worth

$26.69
current
$31.75
average

Events

List of events that could affect this stock.

12May

Earnings data Q1 2020

06Aug

Earnings data Q2 2020

Earnings

The value each share was expected to gain vs. the value that each share actually gained

0
-0.34
-0.69
-1.03
Q4 2019
Q1 2020
Q2 2020
Q3 2020

Expected EPS
Q3 2020

-$0.52

Actual EPS
Q3 2020

Stats

Market Cap$1,37B
Volume18,54k
Price-to-Earnings Ratio
Dividend Rate
Dividend Yield
1 Year High$31.80
1 Year Low$13.00
Open$29.60
High$30.19
Low$26.29

Buy any stock with any amount of money.

Download the App
Download the app